Abstract
The present study explored activities of orally administrated Houttuynia cordata polysaccharide (HCP) on vascular chronic inflammation which was established by a tail-vein injection of lipopolysaccharide (LPS) once weekly for 6 weeks in rats. Results showed that administration of HCP significantly alleviated chronic inflammation by reducing white blood cell and monocyte counts, together with repairing histological impairment of vascular tissue. Furthermore, vascular protections of HCP were in association with decrease of MDA content, pro-inflammatory cytokines interleukin-1beta (IL-1β) and tumor necrosis factor-α (TNF-α), and enhancement of the activities of antioxidant enzyme superoxide dismutase, catalase, glutathione peroxidase activities. Moreover, HCP exhibited anti-inflammatory responses evidenced by reducing the expressions of Toll-like receptor 4 (TLR4) and NF-kB P65. Meanwhile, the combination of HCP and LPS reduced calcium concentration and CaSR mRNA expression in the vascular tissue. Collectively, these results indicated that HCP suppressed LPS-induced chronic vascular inflammation via calcium-sensing receptor and TLR4/NF-kB pathways in rats.
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
